Information  X 
Enter a valid email address

Medica Group PLC (MGP)

  Print   

Thursday 05 November, 2020

Medica Group PLC

Director/PDMR Shareholding

RNS Number : 2907E
Medica Group PLC
05 November 2020
 

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, has received notification from Dr Stuart Quin, Chief Executive Officer of Medica, that on 4 November 2020 he purchased a total of 27,680 ordinary shares of 0.2p in the Company ("Shares") at a price of 107.3p per Share.

Following this transaction, Stuart Quin has a shareholding of 67,042 shares, representing 0.06% of the issued share capital of the Company.

In addition, the Company also received a notification from Mr Richard Jones, Chief Financial Officer of Medica, that on 4 November 2020 he purchased a total of 18,260 Shares at a price of 109.5p per Share.

Following this transaction, Richard Jones holds 18,260 shares, representing 0.02% of the issued share capital of the Company.

The Notification of Dealing Form for Dr Stuart Quin and Mr Richard Jones can be found below.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dr Stuart Quin

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial notification in each case

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Medica Group PLC

b)

 

LEI

 

213800B8XE5FUSZF5Z16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

 

GB00BYV24996



b)

 

Nature of the transaction

 

 

Market purchase

c)

 

Price(s) and volume(s)

Price (s)

Volumes (s)

107.3

27,680


 

 

 

 

 


d)

 

Aggregated information

-  Aggrated volume

-  Price

 

 

27,680

107.3

e)

 

Date of the transaction

 

 

4 November 2020

f)

 

Place of the transaction

 

 

XLON

 

  1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mr Richard Jones

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification in each case

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Medica Group PLC

b)

 

LEI

 

213800B8XE5FUSZF5Z16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

 

GB00BYV24996



b)

 

Nature of the transaction

 

 

Market purchase

c)

 

Price(s) and volume(s)

Price (s)

Volumes (s)

109.5

18,260




d)

 

Aggregated information

-  Aggrated volume

-  Price

 

 

18,260

109.5

e)

 

Date of the transaction

 

 

4 November 2020

f)

 

Place of the transaction

 

 

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKQBNABDDNDK

a d v e r t i s e m e n t